Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse

Figure 5 Kaplan-Meier curves depicting the maintenance of clinical remission in patients with both a negative fecal immunochemical test and clinical remission > 12 mo relative to all other patients. There was a statistically significant difference in the cumulative remission maintenance rates between patients with both a negative FIT and clinical remission > 12 mo (n = 66) and all other patients (n = 128) (P < 0.0001, log-rank test). The hazard ratio relating relapse risk in patients with both a negative FIT and clinical remission > 12 mo to relapse risk in all other patients was 0.11 (95%CI: 0.04-0.23).